Final Results 2018
Integumen (LSE: SKIN), today announces its final results for the year [...]
Integumen (LSE: SKIN), today announces its final results for the year [...]
Integumen today announces that Labskin AI, the virtual laboratory platform, [...]
Trading update – board changes Trading Update Integumen announces the [...]
Launch of Labskin human skin clone tests for Medical Device [...]
Fionán Murray has joined Integumen as Group Sales Director, and [...]
Turner Pope Investor Evening Integumen is pleased to announce that [...]
Integumen today announces the completion of development and launch of [...]
Proposed Placing and Subscription of £2.518m Acquisition, Placing & Subscription [...]
Labskin secures digital automation and integration through £400,000 Cellulac – [...]
Labskin CBD tests show greater than 99% reduction in bacterial [...]